drugset / Trial / NCT03355638
Treatment of CNV With Aflibercept Combined With Pranoprofen Eye Drops or Nutraceutical Support With Omega-3
RandomizedParallel-groupOpen-labelTreatment
Summary
To determine whether a combination of intravitreal aflibercept and pranoprofen eyedrops or nutraceutical support provides additional benefit over IVA monotherapy for the treatment of choroidal neovascularization in age-related macular degeneration.
Timeline
- Start
- 2016-01
- Primary completion
- 2016-07
- Completion
- 2017-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aflibercept | Protein / enzyme biologic | 0.5 mg | Intravitreal |
| Subject | Omega-3 fatty acids | Unknown | — | Oral |
| Subject | Pranoprofen | Small molecule | 0.1 % | Topical |